Skip to content

Drug interactions

Sofosbuvir + Tucatinib

Severity: Moderate

Sofosbuvir and Tucatinib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tucatinib inhibits intestinal P-glycoprotein and may raise exposure to sofosbuvir, a P-gp substrate. Higher levels of the prodrug could increase absorption of sofosbuvir, though the clinical effect of this is probably small because the active metabolite is formed intracellularly.

What this interaction means in plain words

Sofosbuvir and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Sofosbuvir belongs to Anti Virals; Tucatinib belongs to Oncology.

Evidence level: Low

Why it happens

Tucatinib inhibits P-glycoprotein efflux, increasing sofosbuvir absorption and systemic exposure.

What to do

Monitor for sofosbuvir adverse effects such as fatigue, headache and nausea during coadministration. No empirical dose change is established for sofosbuvir.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Sofosbuvir and Tucatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Sofosbuvir with Tucatinib?

MediHelp rates the interaction as moderate. Sofosbuvir and Tucatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Tucatinib inhibits intestinal P-glycoprotein and may raise exposure to sofosbuvir, a P-gp substrate. Higher levels of the prodrug could increase absorption of sofosbuvir, though the clinical effect of this is probably small because the active metabolite is formed intracellularly.

How serious is the interaction between Sofosbuvir and Tucatinib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for sofosbuvir adverse effects such as fatigue, headache and nausea during coadministration. No empirical dose change is established for sofosbuvir.

What other medicines interact with Sofosbuvir?

MediHelp also lists interactions of Sofosbuvir with, for example, Amiodarone, Apalutamide, Carbamazepine. The full list is on the Sofosbuvir page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in